Site Menu
Search Close Search
Search Close Search
Page Menu

The NeuroNexus Institute at UMass Chan Medical School

Nexus: a connection, hub or junction, a connected group or series, the center or focus.

  • The NeuroNexus Institute at UMass Chan Medical School brings together basic scientists, clinicians and trainees with the goal of understanding nervous system function and dysfunction, leading to improved diagnosis and treatment of neurological, neurodevelopmental and psychiatric disorders.
  • Institute faculty also teach, supervise, and mentor the next generation of academic and industry leaders, medical practitioners and educators. 
  • Our community also reaches out to increase public awareness of nervous system function and diseases, of fact-based scientific investigation, and to reduce the stigma of neurological and psychiatric disorders.

Our Mission: From Discoveries to Therapies

The mission of the NeuroNexus Institute at UMass Chan Medical School is to catalyze interactions between basic scientists and translational or clinician scientists, forming interdisciplinary teams that tackle innovative projects, achieve breakthroughs in basic neuroscience knowledge, and accelerate development and implementation of innovative therapies to treat neurological conditions.

Our Vision

To integrate our extensive local community of basic and clinical neuroscientists into a hub of interactions, leading to innovation, discovery, and development of new treatments for neurological disorders, and attract diverse funding sources.

Our Approach is to:

  • Understand principles of nervous system physiology
  • Leverage these principles of neuroscience to understand disease mechanisms
  • Accelerate treatments
  • Educate future generations of academic leaders and medical practitioners
  • Impact patient care
  • Reach out and Educate the public of the Commonwealth of Massachusetts and beyond

Mission and Vision

Getting Results…
  • UMass ALS Cellucci Fund Boston Marathon Team racing for a cure

    UMass ALS Cellucci Fund Boston Marathon Team racing for a cure

    UMass ALS Cellucci Fund Boston Marathon teams have raised more than $800,000 for ALS research since 2012. This year’s team hopes to add $50,000 to that.

    Read more
  • Paul J. DiMare Foundation makes $35 million gift to support neurodegenerative, genetic disease research at UMass Chan

    Paul J. DiMare Foundation makes $35 million gift to support neurodegenerative, genetic disease research at UMass Chan

    UMass Chan Medical School is announcing a $35 million philanthropic gift from the Paul J. DiMare Foundation to advance research and support breakthroughs in neurodegenerative and genetic diseases.  

    Read more
  • Nils Henninger study explores link between traumatic brain injury and onset of ALS/FTD

    Nils Henninger study explores link between traumatic brain injury and onset of ALS/FTD

    New study led by Nils Henninger, MD, PhD'18, suggests interplay between genetic factors and traumatic brain injury in behavioral and neurological deficits related to ALS and FTD in mice.

    Read more
  • Science for Living: Neurology chair and VA neurology chief, A.M. Barrett, highlights veterans’ link to ALS

    Science for Living: Neurology chair and VA neurology chief, A.M. Barrett, highlights veterans’ link to ALS

    Military veterans face a higher risk of ALS than the civilian population, according to years of studies. UMass Chan researchers are pursuing therapies to address the biological basis for this fatal neurodegenerative disease and work with clinical partners to provide expert rehabilitation for veterans.

    Read more